- Home
- VTSI vs NRXP Comparison
VTSI vs NRXP Comparison
Compare VTSI & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VTSI | NRXP |
|---|---|---|
| Founded | 1993 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.9M | 63.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VTSI | NRXP |
|---|---|---|
| Price | $4.78 | $2.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $7.00 | ★ $30.50 |
| AVG Volume (30 Days) | 53.9K | ★ 461.9K |
| Earning Date | 11-10-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $24,934,267.00 | $242,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.39 | $643.59 |
| P/E Ratio | $331.53 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.57 | $1.17 |
| 52 Week High | $7.49 | $6.01 |
Technical Indicators
Market Signals| Indicator | VTSI | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 35.80 | 37.62 |
| Support Level | $4.79 | $2.22 |
| Resistance Level | $5.13 | $2.39 |
| Average True Range (ATR) | 0.14 | 0.15 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 7.55 | 4.26 |
Price Performance
Historical ComparisonAbout VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.